Isabel Miras Rodríguez

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Institut Català d'Oncologia(Current)

Hospital Universitario Virgen del Rocío

Institut Català d'Ornitologia

Centro Oncológico de Galicia

Hospital Universitari i Politècnic La Fe

Isabel Miras Rodríguez is an author at Institut Català d'Oncologia specializing in oncology, bladder cancer radiotherapy, and muscle-invasive bladder cancer therapy.

ORCID

Publications per year

2021–2025

Publications

Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy (RT) in patients (pts) with localized muscle invasive bladder cancer (MIBC) treated with a selective bladder preservation approach: IMMUNOPRESERVE-SOGUG trial.

Xavier García del Muro, Begoña P. Valderrama, Ana Medina et al. · Journal of Clinical Oncology · 2021 · 34 citations

Medicine, Oncology, Urology +17

Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial

Xavier García del Muro, Begoña P. Valderrama, Ana Medina et al. · Clinical Cancer Research · 2025 · 14 citations

Medicine, Oncology, Radiation Oncology +17

1–2 of 2